1989.-The effects of sympathoadrenal manipulations on the exercise-induced alterations in blood glucose, plasma free fatty acids (FFA), and insulin were investigated in intact and adrenodemedullated rats. Exercise consisted of strenuous swimming against a countercurrent for 15 min. Before, during, and after swimming, blood samples were taken through a permanent heart catheter. Adrenodemedullation (Adm) markedly reduced the exercise-induced increase in both glucose and FFA. This effect was counteracted by intravenous infusion of epinephrine (E, 20 ng/min). Intravenous infusion of 50 ng E/min into Adm rats caused an exaggerated increase in glucose. In two additional experiments 1) specific adrenoceptor agonists and antagonists were administered to exercising intact and Adm rats, and 2) E or norepinephrine (NE; 20 ng/min) was infused into intact resting rats. The results suggest that E from the adrenal medulla directly affects glucose and insulin but not FFA concentrations in the blood. NE released from peripheral sympathetic nerve endings probably acts in two different ways: as neurotransmitter on liver and pancreas and as a hormone on adipose tissue. exercise; adrenal medulla, sympathetic nerve endings; adrenergic agonists and antagonists DURING EXERCISE the sympathoadrenal system is activated to increase the supply of glucose and free fatty acids (FFA) to the working muscle (4, 6) . Recent findings in our laboratory demonstrated that in rats a functional dissociation appears between the release of epinephrine (E) by the adrenal medulla and the release of norepinephrine (NE) by the peripheral nerve endings of the sympathetic nervous system (13) . However, a complete dissociation does not occur in vivo, since the release of NE by the peripheral nerve endings is influenced by adrenal E via adrenergic presynaptic mechanisms (13) .
At present, data available regarding the role of the two branches of the sympathoadrenal system on glucose and FFA metabolism during exercise are conflicting. According to Winder et al. (2, 3, 24) , adrenal E is not essential for hepatic glycogenolysis. They concluded that release of glucose by the liver is due to the activation of hepatic sympathetic nerves (22, 23) . In contrast, Galbo and coworkers (16) failed to find any effect of hepatic denervation on hepatic glucose metabolism during exercise. They showed in their experiments that adrenal medullary hormones enhance net glycogen breakdown in liver (11, 12, 16) . With regard to FFA metabolism, it is generally accepted that during exercise enhanced sympathoadrenal activity is responsible for the increase in lipolysis. However, almost no information is available with respect to the relative contribution of adrenal E and/or sympathetic NE in this process. The adrenal medulla seems to be involved, since infusion of E into the blood circulation resulted in enhanced plasma FFA levels in resting rats (19) . But also NE, released after activation of the sympathetic nervous system, seems to play an important role in the release of FFA from adipose tissue (19, 25) . However, it should be noted that white adipose tissue is not directly innervated by sympathetic nerve endings (14) .
Indirect actions of the sympathoadrenal system, for example on insulin release by the pancreatic P-cell, may also interfere with the regulation of glucose and FFA levels during exercise. According to Richter et al. (11, l2) , hormones from the adrenal medulla initiate the reduction in plasma insulin concentrations during exercise. In addition, infusion of E into the blood circulation of resting rats reduced plasma insulin concentrations (19) . On the other hand, activation of the sympathetic nervous system may exert a reduction in plasma insulin levels. It is well known that stimulation of the pancreatic splanchnic nerves inhibits the release of insulin from the P-cell of the endocrine pancreas (25) . However, infusion of NE into the blood circulation of resting rats did not affect plasma insulin concentrations (19) .
In summary, during exercise catecholamines are released from the sympathoadrenal system, and this is followed by an increase in glucose and FFA release. The aim of the present study was to distinguish the adrenal medullary and sympathetic influences on glucose and FFA metabolism during exercise. Recently we showed that adrenal and sympathetic nerve activity can be dissociated by means of adrenodemedullation and/or administration of adrenoceptor agonists and antagonists (13) . Therefore, in the present study, exercise-induced alterations in blood glucose, plasma FFA, and insulin concentrations were measured in adrenodemedullated and control rats, with and without administration of adrenoceptor agonists and antagonists. Surgery. All surgery was performed under ether anesthesia. All animals were provided with a silicon heart catheter through the right jugular vein externalized on the top of the skull according to the techniques described earlier (18). This method allows frequent repeated blood sampling in unanesthetized undisturbed freely moving rats (17, 21) . Whenever intravenous infusions were to be performed, the rats were provided with a smaller second silicon heart catheter implanted in the contralateral (left) jugular vein (19). Because of its small size, this second catheter did not prevent venous return from the head of the animals. Experiments started 1 wk after insertion of the heart catheter(s) when the rats were above preoperative weight. In certain experiments the rats were surgically adrenodemedullated 2 wk before the insertion of the heart catheter(s) to enable adrenocortical regeneration. During the recovery period the rats did not require much saline as drinking water. Adrenodemedullation was verified histologically after termination of the experiments.
Medullary tissue was completely absent in the recovered rat after correct adrenodemedullation. Only the results of completely adrenodemedullated rats were presented.
Exercise. Exercise was performed in a pool made of stainless steel (length, 3.00 m; width, 0.40 m; and depth, 0.90 m) filled 70% with water of 33 t 2°C. At one end the pool was equipped with a starting platform (33 x 37 cm) placed -2 cm above the water surface. This starting platform could be lowered into the water down to the bottom of the swimming pool. A water pump (Loewe, Silenta) provided a marked countercurrent (0.22 m/s) that forced the animal to swim continuously.
At the end of the exercise period, a removable resting platform (20 x 37 cm) was offered to the swimming rat at the upstream side of the swimming pool. The rats readily learned to climb on this lighted and warmed platform within 2 min after it was presented. The rats were accustomed to the experimental exercise conditions six to seven times before the onset of the actual experiments to eliminate emotional stress of novelty.
Blood-sampling procedure. Forty minutes before the start of an experiment, the animals were connected with a polyethylene blood-sampling tube (0.4 m length; 1.45 mm OD, and 0.75 mm ID) through which blood was sampled as described earlier (17). Blood samples of 0.35 ml were withdrawn for determination of blood glucose, plasma FFA, and insulin concentrations.
After each blood sample, a transfusion of 0.35 ml of titrated donor blood was given to avoid diminution of the blood volume with related changes in hemodynamics.
Donor blood was obtained from unstressed rats with permanent heart catheters. Between the withdrawal of blood samples, the tip of the heart catheter was filled with 6% citrate solution as an anticoagulant.
Citrate was used to avoid activation of endothelial lipase. Experimental procedure. All experiments were performed in the light period between 1000 and 1300 h. On the experimental day, food was removed 1.5 h before the onset of the experiment. To measure basal levels of the blood components, two blood samples in a lo-min interval (at t = -11 and -1 min) were taken in the home cage of the undisturbed rat. Subsequently, the rat was placed for 20 min on the starting platform of the swimming pool. Blood samples were taken at t = 1.5, 10, and 20 min after the transfer from home cage to starting platform. Immediately after the t = 20-min blood sample, the starting platform was slowly lowered to the bottom of the swimming pool. This lasted for -5 min, and after -2 min, one blood sample was taken. The moment the rat started to swim was defined as t = 0 min. Then the animal had to swim vigorously against the countercurrent for 15 min. Blood samples were taken at t = 1, 5, 10, and 15 min. At the end of the exercise period, the resting platform was lowered. Postexercise blood samples were taken at t = 19, 24, 29, and 39 min.
Administration of pharmacological compounds. In experiment III, adrenoceptor agonists and antagonists were intravenously administered before and during exercise. Administration of the adrenoceptor agonists E and fenoterol was performed by infusion of the drug through the small second heart catheter. The infusion was started immediately after the last blood sample on the starting platform (t = 20 min), and the infusion was continued for 20 min, i.e., during the lowering of the starting platform and the exercise period. E infusion rates were 20 and 50 ng in 0.1 ml saline/min. Ascorbic acid (0.1%) was added to prevent oxidation of E. The ,&-selective adrenoceptor agonist fenoterol (Boehringer-Ingelheim) was infused at a rate of 7 pg in 0.1 ml saline/min. The adrenoceptor antagonists ICI 118551 (&selective, ICI Pharma) and yohimbine &-selective, Sigma) were given in a single dose (0.1 and 0.13 mg/rat, respectively) before exercise. They were dissolved in 0.1 ml saline and injected intravenously together with the donor blood after the blood sample at t = 10 min on the starting platform.
Chemical determinations. Blood samples were immediately transferred to chilled (OOC) centrifuge tubes containing 0.01% EDTA and 10 ~1 heparin solution (500 U/ ml) as an anticoagulant. Blood glucose was measured by the ferricyanide method of Hoffman (Technicon AutoAnalyzer TM II) with 0.05 ml blood taken from the 0.35-ml sample. The remaining 0.3 ml blood was centrifuged for 15 min at 5,000 rpm at 4°C. A part of the supernatant (100 ~1) was used for the FFA assay, and 100 ~1 plasma were stored at -30°C for the insulin assay. Plasma FFA were determined in 100 ~1 of supernatant according to the method of Antonis (1) by adapting it for a small volume. The plasma was immediately extracted, and the evaporated extracts were stored at -30°C until determination. Rat-specific plasma immunoreactive insulin was determined by means of a radioimmunoassay kit (NOVO, Denmark). Guinea pig serum M8309 served as antiserum. Duplicate assays were performed on 25-~1 samples. The bound and free 1251-labeled 
Statistics. Data are expressed as average change t SE from the basal value at t = -1 min in the home cage. Wilcoxon matched-pairs signed-rank test was used when the levels of the blood components at a certain time during the experiment were compared with the basal value in the home cage. Analysis of variance and MannWhitney U test were applied to determine for each sample point the significant differences between a definitive experiment and the control experiment. The criterion of significance was set at P C 0.05.
EXPERIMENTSANDRESULTS Experiment
I. Control experiment.
The aim of the control experiment was to study the effect of exercise on blood glucose, plasma FFA, and insulin concentrations under the given experimental conditions. Twelve rats, well accustomed to the whole experimental procedure, participated in this study. The results are presented in Table 1 and Fig. 1 . Table 1 shows the absolute basal levels at t = -1 min, in the home cage, of blood glucose, plasma FFA, and insulin in all experiments, and Fig. 1 presents the changes toward basal values in blood glucose, plasma FFA, and insulin in the control experiment. Ten minutes after transfer of the rat to the starting platform, blood glucose concentrations were significantly augmented above basal levels. A further increase in blood glucose occurred after 15 min of exercise. Blood glucose levels were maximal at t = 19 and 24 min; thereafter a rapid decrease occurred. Plasma FFA levels increased during exercise with maximal levels in the first two blood samples after swimming. The increase in plasma FFA above basal levels was significant at the time points t = 10, 15, 19, 24, 29, and 39 min during and after exercise. Plasma insulin concentrations were slightly but not significantly reduced in the period on the starting platform. During exercise a further significant decline in insulin levels occurred. After exercise, plasma insulin returned to basal levels with a slight decline in the last samples at t = 29 and 39 min. Plasma insulin levels were significantly changed from basal levels at t = 5, 10, 15, and 39 min during and after exercise.
Experiment II. Adrenodemedullation. Nine bilaterally adrenodemedullated (Adm) rats were submitted to exercise to investigate the role of the adrenal medulla on blood glucose, plasma FFA, and insulin concentrations during exercise. The results are presented in Table 1 and Fig. 2 . Basal levels of plasma insulin in Adm rats were significantly lower than the control values in intact rats. The exercise-induced increase in blood glucose and FFA was reduced in Adm rats (significant at t = 1, 5, 10, 15, 19,24, and 29 min for glucose and t = 19,24, and 29 min for FFA). The alternations in plasma insulin concentrations during exercise in Adm rats were not different from those in the control experiments. During recovery on the resting platform, a significant reduction in plasma insulin concentrations in Adm rats in comparison with the control values occurred at t = 24 and 29 min postexercise. catecholamine levels in exercising intact and Adm rats (13). The effect of these pharmacological interventions on blood glucose, plasma FFA, and insulin were investigated in this composed experiment. In Experiment 11&.z, the &-selective adrenoceptor antagonist ICI 118551 was administered intravenously into six intact rats to suppress NE release from the peripheral nerve endings of the sympathetic nervous system (13). The effects on blood glucose, plasma FFA, and insulin are presented in Table 1 and Fig. 3A . The injection of the ,&-antagonist reduced blood glucose for the rest of the experiment in comparison with the control experiment (significant at all sample times except for t = 39 min). Plasma FFA levels were slightly reduced during exercise (significant during lowering of the starting platform), and plasma insulin concentrations were not significantly changed in comparison with the control experiment. In experiment Mb, the ,&selective adrenoceptor agonist fenoterol was infused intravenously during exercise into five Adm rats. This led to high plasma NE concentrations (13). The results are presented in Table  1 and Fig. 3B 1, 5, and 10 min for FFA, and at all time points during and after infusion for insulin).
In experiment MC, a physiological dose (20 ng/min) of E was infused intravenously during exercise into six Adm .08
rats to restore the normal NE and probably also E experiment were not different from Adm and/or normal pattern (13). Blood glucose, plasma FFA, and insulin values. Experiment IIIe consisted of a single intravenous alterations are presented in Table 1 and Fig. 3C . Blood injection of the az-selective adrenoceptor antagonist yoglucose and plasma FFA were significantly enhanced himbine at t = 10 min on the starting platform combined above Adm levels at t = 1, 5, 10, 15, 19, 29, and 39 min with an intravenous infusion of the &-selective adrenofor glucose and at t = 19 and 24 min for FFA. Blood ceptor agonist fenoterol during exercise in four Adm rats. glucose and plasma FFA levels showed a remarkable This leads to extremely high plasma NE concentrations similarity with the values in normal exercising rats in (13). The results are presented in Table 1 and Fig. 3E . the control experiment. Plasma insulin levels were not Injection of the az-adrenoceptor blocker caused an inchanged during infusion in comparison with Adm or crease in plasma insulin concentration and a decline in normal exercising rats. Infusion of a high dose (50 ng/ blood glucose. Plasma FFA seemed not affected by cy2-min) of E into five Adm rats (expt IIId, results in Table  blockade . An increase in blood glucose levels occurred 1 and Fig. 30 C.-effect of an intravenous infusion of 20 ng epinephrine (E)/min on plasma FFA, blood glucose, and plasma insulin concentrations in exercising Adm rats (M).
Control experiments with intact (----) and Adm ( -) rats are depicted. Data are expressed as in B. D: effect of an intravenous infusion of 50 ng E/min on plasma FFA, blood glucose, and plasma insulin concentrations in exercising Adm rats (M).
Control experiments with intact ( ----) and Adm (-) rats are depicted. Data are expressed as in B. E: effect of intravenous injection of the crz-selective adrenoceptor antagonist yohimbine in combination with an intravenous infusion of the &-selective adrenoceptor agonist fenoterol on plasma FFA, blood glucose, and plasma insulin concentrations in exercising Adm rats (w).
Control experiments with intact ( ----) and Adm (-) rats are depicted. Data are expressed as in A and B. FFA, and t = 1, 5, 10, 15, 19, 24, 29 , and 39 min for insulin.
Experiment IV. Intravenous infusion of E and NE. To investigate the hormonal effects of E and NE on blood glucose, plasma FFA, and insulin concentrations, either E (20 ng in 0.1 ml saline/min) or NE (20 ng in 0.1 ml saline/min) was infused for 15 min into the blood circulation of seven resting rats. The infusion was administered through the small heart catheter between t = 0 and 15 min, and blood samples were withdrawn at t = -11, -1, 1, 5, 10, 15, 17, 22, 27, and 37 min for determination of blood glucose, plasma FFA, and insulin. The results are presented in Table 1 and Fig. 4, A and B . Infusion of 20 ng E into the blood circulation caused a significant increase in blood glucose within 10 min after start of the infusion. Plasma insulin levels were reduced during E infusion and increased immediately after termination of the infusion. Plasma FFA levels were not changed during infusion of E but a reduction in plasma FFA concentrations occurred after termination of the infusion. The changes in blood glucose, plasma FFA, and insulin were significant at t = 10, 15, 17, 22, 27 min, t = 27 min, and t = 1 min, respectively. Infusion of 20 ng NE/min had only an effect on plasma FFA concentrations. Plasma FFA levels were significantly increased at t = 22 min.
DISCUSSION
Blood glucose and plasma FFA concentrations increased during exercise in control rats, suggesting that the production and release of glucose and FFA highly exceeded the expenditure of these energy substrates. Plasma insulin levels declined, probably due to a diminished release of insulin by the pancreatic ,&cell (6). These changes in glucose, FFA, and insulin concentrations G the result of an activation of the sympathoadrenal system during exercise, as reflected by increased concentrations of E and NE in the blood circulation (4, 6, 13) . Accordingly, blood glucose and plasma FFA concentrations are affected by alterations in sympathoadrenal activity. Recently (13) we showed that Adm caused a 60% reduction in the exercise-induced increase in plasma NE concentrations. Plasma E was not detectable in Adm rats. In the present study, Adm led to a marked reduction in the exercise-induced increase in both blood glucose and plasma FFA concentrations. The reduced catecholamine levels in the Adm rats had only a minor effect on plasma insulin alterations during exercise. This seemingly suggests that the markedly reduced increase in sympathetic activity as indicated by low plasma NE levels in Adm rats is still sufficient to inhibit insulin release during exercise. However, it should be noted that different blood glucose levels in Adm and control rats may interfere with Infusion of 20 ng E/min into Adm rats completely restored the normal increase in plasma NE levels during exercise (13). In the present study the infusion of 20 ng E/min into Adm rats also restored blood glucose and plasma FFA patterns toward control values (see Fig. 3C ).
Infusion of a high dose of E (50 ng/min) into exercising Adm rats caused an exaggerated increase in blood glucose compared with control animals and Adm rats infused with 20 ng E/min (see Fig. 30 ). Plasma FFA concentrations were lower than control values after infusion of 50 ng E/min and did not differ from those of exercising Adm rats. These results suggest a relation between plasma E and blood glucose concentrations. In a previous study with nonexercising rats (19), however, we showed that intravenous infusion of 50 ng E/min increased plasma FFA concentrations besides an increase in blood glucose and a decrease in plasma insulin. This seems in contrast to the results of the present study. It might be that the increase in plasma FFA after infusion of 50 ng E in the nonexercising animals may be due to a change in the rate of reesterification of FFA. Because insulin is required for this process, reduced plasma insulin concentrations during 50-ng E infusion in the previous study may have led to reduced reesterification and then to an increase in plasma FFA concentrations.
In the present study a near-physiological dose of 20 ng E/min was infused into nonexercising rats. This still resulted in an increase in blood glucose and a reduction in plasma insulin during infusion (see Fig. 4A ). Plasma FFA concentrations were not affected. Accordingly, E in a physiological range does not directly influence lipolysis. After termination of the E infusion plasma insulin concentrations were increased, and blood glucose returned to preinfusion levels. The facilitated entry of glucose into adipocytes, affected by insulin, probably caused an increase in the reesterification of FFA, resulting in a decline in plasma FFA concentrations immediately after termination of the infusion.
In conclusion, the results of the present study with exercising and nonexercising rats suggest that E, originating from the adrenal medulla (13), directly affects blood glucose and plasma insulin concentrations. The effects of E on plasma FFA concentrations seems secondary to the alterations in blood glucose and in particular plasma insulin concentrations.
Circulating NE appeared to act exactly in the opposite way. In exercising Adm rats, infusion of 20 ng E restored both plasma NE (13) as well as plasma FFA concentrations toward control values (see Fig. 3C ). After infusion of the high dose of 50 ng E in exercising Adm rats, both plasma NE (13) and FFA levels were relatively reduced (see Fig. 30 ). In nonexercising rats, infusion of 20 ng NE/min increased plasma FFA concentrations (see Fig.   4B ). Blood glucose and plasma insulin concentrations were not influenced by NE infusion. The same results were also obtained with a higher dose (50 ng/min) of NE in a previous study (19 Infusion of the &selective adrenoceptor agonist fenoterol in exercising Adm rats immediately enhanced blood glucose, plasma FFA, and plasma insulin concentrations (see Fig. 3B ). The effects on blood glucose and plasma insulin were seemingly caused by a direct stimulation of Pa-adrenoceptors on liver, muscle, and pancreatic P-cells (9, 11, 12, 25) . The decrease in blood glucose and plasma insulin concentrations after administration of the ,&-selective adrenoceptor antagonist ICI 118551 to intact exercising rats in the present study may indicate the involvement of ,&-adrenoceptors in the regulation of blood glucose and plasma insulin concentrations. However, it has to be remarked that according to literature, catecholaminergic activation of hepatic glycogenolysis is mediated by a-adrenoceptors rather than by ,&adrenoceptors in adult male rats (5, 20). Alternatively, the increase of blood glucose might be explained by increased muscle glycogenolysis resulting in decreased 'uptake of glucose from the blood. Injection of the CY~-adrenoceptor antagonist yohimbine reduced blood glucose (see Fig. 3E ), suggesting that also az-adrenoceptors are involved in the regulation of blood glucose levels. These cr2-adrenoceptors are located in liver where they stimulate glycogenolysis (5, 22) . Because the present study was performed in Adm rats, the decline in blood glucose after an-blockade suggests that sympathetic NE may have activated the an-adrenoceptors in liver. This is in accordance with findings of Shimazu (14) 
